Prolonged Survival in Patients with Metastatic HER2-Positive Inflammatory Breast Cancer: A Case Report and Review of the Literature

Autor:	Beth Overmoyer, Jennifer Y Ge
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Improved survival Neoplasms. Tumors. Oncology. Including cancer and carcinogens Case Report Disease Favorable prognosis medicine.disease Inflammatory breast cancer Breast cancer stage iv HER2 Positive Breast Cancer Internal medicine her2-positive breast cancer medicine In patient anti-her2 therapy business Stage iv skin and connective tissue diseases inflammatory breast cancer metastatic disease RC254-282
Zdroj:	Case Reports in Oncology, Vol 14, Iss 2, Pp 1071-1079 (2021) Case Reports in Oncology
ISSN:	1662-6575
Popis:	Inflammatory breast cancer (IBC) is a rare type of breast cancer that is associated with poor outcomes compared with non-IBC. Overexpression of HER2 is enriched in IBC, and those with HER2-positive disease have a relatively favorable prognosis, with improved survival over the last two decades driven by the advent of novel targeted therapies. Here, we present two patients who have survived for over 10 years after being diagnosed with de novo metastatic HER2-positive IBC. We review the data for the treatments available for metastatic HER2-positive IBC and the evolving treatment recommendations for this disease.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e47c83d76664c4e9a5c3bced82d4ea42 https://www.karger.com/Article/FullText/516760 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.